ArticleChemical science2026
Aluminylation: a generalizable route towards low-valent aluminum under moderate conditions with controlled product nuclearity through precursor design.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in isolating and characterizing reactive aluminylenes and aluminyl anions have redefined the landscape of low-valent aluminum chemistry. Study of these molecules that span a wide range of structures and ligand environments have helped established new paradigms in main-group metal bonding and reactivity; however, their controlled access remains limited by aggregation, disproportionation, and oxidation of reactive Al(i) intermediates. Herein, we establish aluminylation as a generalizable redox-neutral synthetic route to low-valent aluminum complexes. By circumventing the use of external reductants through metathesis reactions between Al(i) precursors and alkali metal ligand salts, we can access novel heteroleptic clusters as well as known aluminyl complexes with improved yields or under more mild conditions. We demonstrate that the equilibrium of the Al(i) precursor between monomeric or oligomeric cyclopentadienyl aluminum species directly governs reaction outcomes and enables selective formation of products across multiple ligand classes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.